Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Over-the-Counter Human Use; Proposed Amendment of Monograph for OTC Bronchodilator Drug Products; Correction

Samenvatting

The Food and Drug Administration (FDA) is correcting a proposal that appeared in the Federal Register of March 9, 1995 (60 FR 13014). That document proposed to amend the final monograph for over- the-counter (OTC) bronchodilator drug products to remove pressurized metered-dose aerosol container dosage forms for the ingredients epinephrine, epinephrine bitartrate, and racepinephrine hydrochloride. The document was published with two errors. This document corrects those errors.